RNF32

Across TCGA pan-cancer cohorts, RNF32 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated RNF32 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNF32 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated RNF32 expression acts as an unfavorable survival marker, although some lineages such as UCEC and STAD show a favorable association.

UCEC, OV, and ACC are the cancer types where RNF32 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	1.000	0.432	.005	34	view →
OV	DFS	Median	All	0.168	0.541	.005	18	view →
ACC	DFS	Median	All	0.089	0.666	.017	6	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →
STAD	OS	Median	III,IV	1.000	0.362	.039	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNF32–UCEC (DFS)

Open the UCEC breakdown →